National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Islet Cell Tumors (Endocrine Pancreas) Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 05/06/2008



Description






Stage Explanation






Treatment Option Overview






Gastrinoma






Insulinoma






Glucagonoma






Miscellaneous Islet Cell Tumors






Recurrent Islet Cell Tumors






To Learn More About Islet Cell Tumors (Endocrine Pancreas)






Get More Information From NCI






Changes to This Summary (05/06/2008)






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Recurrent Islet Cell Tumors

Treatment depends on many factors, including what treatment the patient had before and where the cancer has come back. Treatment may be chemotherapy, or patients may want to consider taking part in a clinical trial.

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent islet cell carcinoma.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov